What are the responsibilities and job description for the Genomics Scientist position at Garuda Therapeutics, Inc.?
Garuda Therapeutics is looking for a Genomics Scientist with a focus on genomics, molecular biology, and next generation sequencing.
Located in Cambridge, MA, Garuda Therapeutics is pioneering the development of off-the-shelf hematopoietic stem cell (HSC)-based cellular therapies for treating patients with blood, bone marrow, immune, and metabolic disorders. The company uses state-of-the-art technologies in developmental biology, gene-editing, stem cells, and mechanobiology to engineer safe, compatible HSCs in scalable quantities to transform the lives of patients in need of an HSC-transplant.
This individual will be responsible for clinical R&D, validation/verification of diagnostic molecular tests, and production implementation of tests. They will work collaboratively in an interdisciplinary team of genomics scientists, disease area biologists and computational biologists to apply genomic technologies to further discovery efforts. This individual will also contribute to SOP development and improvement.
- Bachelor’s or Master’s Degree in Molecular/Cell Biology, Genetics, Genomics, Biochemistry or a related field with at least 5 years (Master’s) or 10 years (Bachelor’s) of extensive genomics experience in an academic or industry setting; OR, a Ph.D. in genetics, genomics, oncology or a related field with a proven applied genomics track-record
- Must have an understanding of genomics, molecular biology, and technologies such as qPCR and next-generation sequencing
- Experience working with relevant genomic databases and browsers and their annotations
- Demonstrated proficiency in the analysis of large-scale transcriptomics data and experience with a broad spectrum of relevant open-source software
- A deep understanding of molecular biology and biochemical techniques relevant to assay development
- Candidates with substantial experience in cell culture, nucleic acid extractions, qPCR, DNA sequencing, immunoassays, or flow cytometry are preferred
